"The overall message is that the drug-safety evaluation system is not working," says co-author Curt Furberg, a medical epidemiologist at Wake Forest University in Winston-Salem, N.C., and former member of the FDA's drug safety and risk management advisory panel. "Harmful drugs are getting into the marketplace."
Another possible explanation: Doctors and patients simply have become more likely to submit the voluntary adverse-event reports, especially in light of high-profile safety withdrawals and lawsuits, the study's authors write. But if that were true, they say, reports would have increased for all medications, which was not the case. . .
In addition, reports of serious reactions not mentioned on a label represented 87% of the increase from 1998 to 2005, the authors write.